Medium spiny neuron

From WikiMD's WELLNESSPEDIA

Medium Spiny Neuron is a type of GABAergic inhibitory neuron that makes up approximately 95% of the neurons within the striatum, a major component of the basal ganglia. Each medium spiny neuron has a roughly spherical cell body, numerous spiny dendrites, and a single, long, branching axon. These neurons are known for their long spines, where the majority of the synapses occur.

Structure[edit]

Medium spiny neurons are characterized by their medium-sized cell bodies and the numerous spines that cover their dendrites. These spines are the main sites of synapses, where signals from other neurons are received. The axon of a medium spiny neuron is long and highly branched, allowing it to send signals to many other neurons.

Function[edit]

Medium spiny neurons are primarily involved in the processing of information related to movement, reward, and learning. They receive input from the cortex and the thalamus, and send output to other parts of the basal ganglia. The activity of these neurons is modulated by dopamine, a neurotransmitter that is involved in reward and motivation.

Clinical significance[edit]

Abnormalities in medium spiny neurons have been implicated in several neurological and psychiatric disorders, including Huntington's disease, Parkinson's disease, and schizophrenia. In Huntington's disease, for example, there is a loss of medium spiny neurons in the striatum, leading to movement problems and other symptoms.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.